Key Factors Driving Global Photopolymerization Market in Medical Applications!

A new market research report by Transparency Market Research on the global photopolymerization market in medical applications offers an overview of the current scenario of the market and points out the various factors impacting the growth of the market. The report, titled “Photopolymerization in Medical Applications Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” projects the growth and valuation of the market during the period between 2015 and 2023. The report studies the growth of the global photopolymerization in medical applications market across some of the key geographical segments. The competitive landscape of the market has been also discussed in the report.

Photopolymerization refers to the conversion of liquid resin into insoluble polymer material through

irradiation with a light source. The radiated light is usually in the ultraviolet or visible region of the electromagnetic spectrum and interacts with light-sensitive compounds known as photoinitiators to create free radicals. These free radicals further initiate polymerization of monomers, oligomers, and other components to form rigid polymers. Photopolymerization technology finds application in the manufacture of domestic appliances, electronic gadgets, automotive products, and food and beverage containers. The technology has become widely popular for the manufacturing of medical devices, as the UV curing process prevents degradation of the lubricious coatings on balloon catheters and guide wires.

Request a PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4745

On the basis of application across the medical sector, the report segments the global photopolymerization market in medical applications into 3D imaging, dentistry, medical devices, and drug delivery. UV curing technology is used for a number of medical devices such as endoscopes, catheters, syringes, cannulae, insulin pens, angioplasty accessories, endotracheal tubings, blood oxygenators, and others. Irgacure is one of the most commonly used photoinitiators for medical applications.

The process of UV curing can be performed with the help of flood curing and spot curing technology. While flood curing systems deliver light to a larger area, spot-curing systems deliver high amounts of focused energy into relatively small areas. Spot-curing is the most widely used bonding technology in medical product applications.

The report studies the photopolymerization market in medical applications across four key regions: Europe, North America, Asia Pacific, and Rest of the World. North America and Europe are the major markets for photopolymerization in medical applications. However, during the forecast period, growing demand from the emerging economies in Asia Pacific is expected to significantly contribute towards the growth of the market.

The report profiles some of the key players in the global photopolymerization market in medical applications such as Ciba Specialty Chemicals Inc., BASF Corporation, DSM Biomedical, Heraeus Noblelight Fusion UV Inc., Nordson Corporation, Lumen Dynamics Group Inc., and Henkel Corporation. A number of companies are focusing on ultraviolet cured photopolymers to achieve environmental compliance as well as improve customer satisfaction.

Biological Machines Market Research Report, 2013-2019

Biological machines are cellular devices designed to perform various functions such as protein expression, sensing, transport, information processing and actuation in a micro-environment. Also known as cellular systems, biological machines are used as tools for biological repair, implants for drug release, synthesis and sensing and also as organ mimics for drug testing. Rapid convergence of engineering and biotechnology is assisting in the development of biological machines. The biological machines market is in its developing phase characterized by under research and development technologies. 

A number of universities and research organizations are involved in the research and development activities for biological machines. For instance, bioengineers at the University of Illinois are trying to print biobots using 3D printers. The bioengineering department of the university currently aims to develop biological materials that can perform certain biological repair tasks. They have managed to print biobots from a combination of muscle cells and gel, which is a stepping stone towards one day printing of functional organs for implantation. Funded by the National Science Foundation (NSF), the research team at the University of Illinois will be developing simple biological materials using muscle cells and then proceed to genetically engineer cells that respond to light in predictable ways, allowing the creation of controllable biobots.

This research is being performed at the NSF Science and Technology Center in the U.S., with other research partners at the Massachusetts Institute of Technology (MIT), the Georgia Institute of Technology and minority-serving partners at City College of New York, Morehouse College (Atlanta, U.S.) and University of California at Merced (UCM). The NSF had granted USD 25 million in 2010, for a five-year term to establish the Emergent Behaviors of Integrated Cellular Systems Center (EBICS) each at MIT, University of Illinois and the Georgia Institute of Technology.

Request a Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2335 

Besides healthcare, biological machines find applications in other aspects that potentially effect health. Researchers from the Imperial College London have demonstrated a way of developing a new type of biological wire using proteins, which interacts with DNA and act as wires in an electrical circuitry. This new wire has the capability of being re-engineered over and again to create billions of connections between DNA components. Re-wiring of DNA in yeast can aid in performing various tasks such as detecting contaminants in water supplies and recording environmental conditions in the production of biofuels.

Once successful, new organs can be designed and implanted using biological robots which have the ability to sense drug or glucose levels in the blood stream and respond accordingly by stimulating or inhibiting the secretion. Biorobots can be used to perform nanoscale tasks inside the human body. Retinal implants, sensory systems, cortical implants, auditory system, nanotube electrodes and other such products can be developed using biological machine technology. Principles of cellular systems are applied to develop these biological machines i.e. implants and nanoscale products that can perform small tasks in the human body.

Being at its nascent stage, the biological machines market is profound in the developed countries of North America and Europe. Approval of biological machines by the FDA and other regulatory authorities will require additional time as these machines directly react with the biological systems. The market for biological machines in the developing regions is still far from development owing to slower rate of acceptance and lack of advanced healthcare infrastructure. 

Global Biodefense Market to Capitalize on Rising Threat of Bioterrorism

In the last few years, biodefense has emerged as a popular method to combat the potential negative effects of bioterrorism, which is spread by biological agents or deployed using biological weaponry. The rising threat of bioterrorism and the subsequent proliferation of disease surveillance missions have driven the market for biodefense around the world.

In its report, titled “Biodefense Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” Transparency Market Research provides a comprehensive overview of the global market for biodefense. It covers aspects such as the market’s definition, segmentation based on various parameters, and factors impacting the market’s growth trajectory.

Bioterrorism refers to the deliberate release of biological agents such as viruses, bacteria, toxins, or germs, which may be naturally occurring or in modified forms, in order to disseminate infections or to cause illness or death. While these germs are often found in nature, bioterrorism makes them more virulent by enhancing their potential to spread infections or by making them drug-resistant. It is possible to disseminate these biological agents through air, water, food, or from person to person. At an initial stage, these infections can be hard to detect, since they do not show any symptoms in the first few hours or days. Biodefense has emerged as a potential solution to protect people against bioterrorism.

Biodefense is deployed in two ways. It is either used as defense against an attack on a civilian population or on a military target. Ensuring defense against attacks on civilian populations is primarily based on the detection of the infection and methods to minimize the casualties and loss of water or food.

Get a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5369

The global market for biodefense is witnessing impressive growth prospects in response to the rising importance of disease surveillance to combat the looming threat of bioterrorism. The attack of September 11, 2001, in the U.S. was followed by the subsequent outbreak of spores, anthrax, and other severe ailments. These events exposed the vulnerability of human society to bioterrorism and made governments from across the world realize the importance of improving their public health scenario, to shorten the response time in the event of similar disasters that may occur in the future.

Funding to improve bioterrorism preparedness has enabled Public Health Service to expand the reach of their surveillance activities significantly and to effectively monitor the community’s health. Such recent incidents are substantially boosting the market for biodefense, which is poised to exhibit exponential growth between 2015 and 2023. Furthermore, the recent outbreak of Ebola, Zika, and the nuclear crisis in Japan are also expected to fuel demand from the biodefense market.

Regionally, North America led the global biodefense market, followed by Europe. North America boasts enhanced lab capabilities and has successfully implemented rapid health alert systems, which aid the expansion of the biodefense market in the region. However, Asia Pacific is likely to emerge as the most lucrative market for biodefense in the near future, with the region exhibiting a high adoption rate of analytical equipment and rapid development of the biotechnology industry. The Middle East and Latin America will also emerge as prospective markets for biodefense over the report’s forecast period.

Health and Wellness Market is Greatly Driven by Expansion of Modern Grocery Retailers

Transparency Market Research opens a discussion about the health and wellness market with its new research report. The research report, titled “Health and wellness Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” provides the readers with a 360-degree view of the health and wellness market and the key trends and dynamics impacting it. Over the years, more and more people have become conscious about their health and overall well-being. This trend has also caught up in several developing countries, with a growing awareness of healthcare devices, supplementary diets, organic food products, exercise equipment, and functional beverages.

The health and wellness market offers a wide range of products such as functional foods, functional beverages, and dietary supplements. The types of functional foods in the market are omega fatty acid fortified food, prebiotics fortified food, branded wheat flour, branded ionated salt, and others. Some of the easily available functional beverages are dairy and dairy alternative drinks, fruit and vegetable juices and drinks, non-carbonated drinks, and others. Meanwhile, the dietary supplements listed in this market are proteins and peptides, vitamins and minerals, herbal and non-herbal supplements, and others.

Product types of cosmeceuticals in this market are cosmeceutical ingredients, cosmeceutical products, and cosmeceutical sales channels. The cosmeceutical ingredients are sunscreen, antioxidants, enzymes, acids, botanicals, proteins, and others. The list of products includes hair care products, skin care products, lip care products, injectables, tooth whiteners, and others. The sales points in the health and wellness market are grocery retailers, non-grocery retailers, store-based retailing, non-store retailing, home shopping, vending machines, and others. Geographically, this market is segmented into Ukraine, Russia, and Kazakhstan.

Request a Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=450

Currently, the health and wellness market in Russia is being fueled by the booming grocery retailing sector. The increasing presence of stores across the country is also improving the consumer awareness of these products. Additionally, rising income levels and growing concerns about health and wellness have also encouraged consumers to spend more on these products all across Russia. On the other hand, impactful advertising campaigns and a strong presence of multinational companies has had a positive impact on the growth of the health and wellness market in Ukraine, Russia, and Kazakhstan.

The key players operating in the health and wellness market are Animas Corporation, Coca-Cola, Omron Healthcare, L’Oréal, B. Braun Melsungen AG, Johnson & Johnson, Nestle S.A., Philips Healthcare, F. Hoffmann-La Roche, General Mills, Inc., Abbott Laboratories, LifeScan, Inc., and Medtronic, Inc. The research report profiles these key players and provides a fair understanding of the competitive landscape of the global health and wellness market. Furthermore, the research report also analyzes the financial status, research and development activities, product portfolio, investment outlook, and strategic mergers and acquisitions of these top players in the market.

Array Instruments Market: DNA Microarray Technology Gains Dominant Market Share

A new Transparency Market Research report states that the global array instruments market stood at US$0.87 bn in 2014 and is predicted to reach US$1.12 bn in 2020. It is predicted to expand at a CAGR of 4.30% from 2014 to 2020. The title of the report is “Array Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”

As mentioned in this study, the rising requirement for the early diagnosis and detection of various types of cancers will fuel the market for array instruments. Furthermore, robotics playing a prime role within laboratory automation will further augment the growth of the market. Array instruments are being employed on a large scale for applications in drug discovery and life sciences, hence stimulating the overall market. On the other hand, the absence of adequate data analysis tools and the decreasing rate of adoption of array instruments in emerging nations owing to their high costs may hamper the growth of the market in forthcoming years. Furthermore, the rising competition from newly emerging technologies may also pose a threat to the market for array instruments.

Avail a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=495

In terms of technology, the report segments the array instruments market into DNA, protein, tissue, and cellular microarrays. Amongst these, the segment of DNA microarray is conventionally used in several applications and is the most broadly accepted technology and hence led the market for array instruments in 2014. This is due to the enhanced precision and accuracy of DNA microarrays and their increasing acceptance amongst a number of end users.

On the other hand, the segment of protein microarray emerged as the second largest and most swiftly developing segment of the market. Increased accuracy in the identification of protein-protein interactions, high sensitivity, and high resolution are amongst the chief factors fuelling the demand for protein microarrays. On the other hand, the segments of tissue microarray and cellular microarray are presently in their early stages and thus have certain limitations. In terms of end use, the market is segmented into clinical diagnostic labs, research and development laboratories, veterinary laboratories, agriculture research centers, and forensic centers.

On the basis of geography, the global array instruments market is segmented into Europe, Asia Pacific, North America, and Rest of the World (RoW). Amongst these, North America led the market in 2014. This is owing to the U.S. being the first site for the adoption of any kind of technological advancement because of the presence of key players in this country. Europe trailed North America and held the second largest share in the market owing to the increasing occurrence of various types of cancers demanding treatment and diagnosis within this region.

As stated in the report, the prime players operating in the market are Illumina, Inc., Affymetrix, Inc., Molecular Devices, LLC, Bio-Rad Laboratories, Agilent Technologies, Inc., Thermo Fischer Scientific, Sigma-Aldrich Corporation, and ArrayIt Corporation, among others.

Nuclear Medicine Market - Global Trends and Forecast 2023

Therapeutic nuclear medicine follows diagnostic nuclear medicine in terms of applications. However therapeutic nuclear medicine being an expensive procedure has the potential to surpass diagnostic nuclear medicine in the future in terms of revenue. On the other hand European companies continue to remain a strong point in the global nuclear medicine market mainly due to the high quality of services offered, greater innovations and their increased reliability. 

For More Details Visit: http://www.transparencymarketresearch.com/nuclear-medicine-market.html 

MEMS in Medical Application Market to Register Growth at 20.2% CAGR due to Increasing Healthcare Expenditure

The research report, titled “MEMS In Medical Applications Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” states that the global MEMS In medical applications market stood at US$1.8 bn in 2012.

A research study on the global market for MEMS in medical applications, recently published by Transparency Market Research (TMR), estimates this market to register an exceptional CAGR of 20.20% during the period from 2013 to 2019 and attain a market value of US$6.5 bn by the end of the forecast period.

According to the study, the rising preference of home-based healthcare over hospitals has stimulated the demand for MEMS in medical application significantly over the past few years. The escalating demand for precision, as well as miniaturization of medical devices, and the increasing need for lab automation are also propelling the market for MEMS in medical applications across the world.

In this report, the worldwide market for MEMS in medical applications has been studied on the basis of application, sensor, end user, and region. As per the study, therapeutic devices are likely to emerge as the biggest application area of MEMS in the medical and healthcare sector over the forecast period due to the extensive utilization of intrathecal pumps and insulin delivery pumps.

Get a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1528

Based on the type of sensor, the pressure sensors segment led the overall market with a total value of US$486 mn in 2012. Analysts at TMR expect this segment to post an impressive growth at a CAGR of 18.70% during the forecast period.Home-based healthcare, hospitals, and healthcare research organizations are the prime end users of MEMS in medical applications, states the study.

The research report regionally segments the global market for MEMS in medical applications into North America, Asia Pacific, Europe, and the Rest of the World. North America dominated the global market in 2012 with an overall value of US$800 mn.

Asia Pacific, on the other hand, is projected to witness the highest CAGR of more than 20.0% during the forecast period. The increasing pool of diabetic patients, coupled with the rising disposable income of people in this region and their changing lifestyle, is the key factor, expected to drive the Asia Pacific market for MEMS in medical applications in the coming years.

The advancements in the economy and the increasing number of reformative government actions for the betterment of healthcare infrastructure in this region are also predicted to support the growth of this market significantly in Asia Pacific, notes the study.Some of the prominent players operating in the global market for MEMS in medical applications are Texas Instruments Inc., STMicroelectronics, Royal Philips Electronics NV, Measurement Specialties, Honeywell Sensing and Control, GE Measurement and Control, Freescale Semiconductor Inc., and Analog Devices Inc., states the research report.

Implantable Drug Delivery Devices Market to Reach US$21.1 bn by 2018 due to Increasing Occurrence of Chronic Diseases

A new Transparency Market Research report states that the global implantable drug delivery devices market stood at US$11.6 bn in 2011 and is predicted to reach US$21.1 bn by 2018. It is predicted to expand at a CAGR of 8.80% from 2012 to 2018. The title of the report is “Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018.”

On the basis of type, the implantable drug delivery devices market is segmented into implantable bio-absorbable stents, implantable coronary drug eluting stents, implantable contraceptive drug delivery devices, implantable brachytherapy seeds, implantable intraocular drug delivery devices, and implantable drug infusion pumps.

According to the report, the market for implantable coronary drug eluting stents is fuelled by the rising demand for minimally invasive procedures and the increasing count of interventional cardiologists globally. On the other hand, the market for implantable brachytherapy seeds is stimulated by the rising occurrence of prostate cancer. The implantable drug infusion pumps market is propelled by the increasing occurrence of colorectal cancer and the increasing prevalence of chronic pain. The market for implantable intraocular drug delivery devices is driven by the rising geriatric population and the soaring count of patients having diabetes and consequently diabetic retinopathy. The implantable contraceptive drug delivery devices market is also augmented by the increasing occurrence of unwanted pregnancies. On the other hand, the strict CE and FDA approval norms, the launch of convenient substitutes, and the introduction of the Affordable Healthcare for America Act, 2010 are amongst the prime factors that may restrain the growth of the market in forthcoming years.

In terms of technology, the report segments the market into non-biodegradable implantable drug delivery device technology and biodegradable implantable drug delivery device technology. On the basis of application, the market for implantable drug delivery devices is segmented into ophthalmology, cardiovascular, oncology, birth control/contraception, and others including chronic pain caused by diseases and diabetes.

Browse More: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=887

In terms of geography, the report segments the market into Europe, North America, Asia, and Rest of the World (RoW). Amongst these, in 2011, North America led the market for implantable drug delivery devices. However, it is predicted that this region will cede its share during the forecast horizon. The region of Asia Pacific is poised to gain a dominant share in the market in the forecast period due to swift development in emerging nations such as India and China within this region.

As mentioned in the report, the chief players operating in the implantable drug delivery devices market are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories, and Bausch and Lomb Inc.

Geriatric Medicines Market Reaping the Benefits of Demographic Shift

The World Health Organization reveals that the proportion of the world’s population over the age of 60 is likely to double from 12% in 2015 to 22% by 2050. By 2020, the number of people above the age of 60 will surpass the number of children below the age of five. Compared to the past, the WHO states that the pace of population aging is much faster today, with almost every country facing severe challenges to make sure their health systems are capable of dealing with this shift in demographics.

The constantly rising size of the aging population is the most important factor driving the global geriatric medicines market. This, combined with the increasing prevalence of chronic diseases and the surge in government support, is projected to fuel the geriatric medicines market in the years to come. 

Surge in Obesity Levels Driving Demand for Geriatric Medicines for Cardiovascular Diseases

The geriatric medicines market is segmented on the basis of condition into arthritis, cancer, respiratory, cardiovascular, neurological, osteoporosis, and others. In terms of revenue, cardiovascular held the largest share in 2014, driven mainly due to the increased effectiveness and efficiency of geriatric medicines. Expanding at the highest CAGR from 2015 to 2023, this segment is also propelled by the increase in obesity levels across the globe, the rise in the number of geriatrics, and the surge in heart attacks and stroke incidences.

On the basis of therapeutic category, the geriatric medicines market is broken down into antihypertensive, antidiabetic, anticoagulant, analgesic, statins, proton pump inhibitors, antipsychotic and antidepressants, and others. Accounting for the largest share in the overall geriatric medicines market, analgesics emerged as the leading segment in 2014 and this segment is projected to retain its lead through 2023. 

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2445

Growth in Healthcare Infrastructure Driving Asia Pacific Market 

The global geriatric medicines market is geographically divided into Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. Accounting for a 39% share in 2014, North America dominated the overall geriatric medicines market in terms of revenue. This region is fueled by the rapidly rising geriatric population and the increasing prevalence of cardiovascular diseases. Europe is the second largest market for geriatric medicines. On the other hand, Asia Pacific – the third largest geriatric medicines market in the world – is projected to emerge as the most rapidly expanding regional segment by 2023, thanks to the rise in government initiatives, the growing proportion of the geriatric population, the expansion of market players in the region, and the rapid growth in healthcare infrastructure. 

The global geriatric medicines market is poised to expand at a 7.30% CAGR from 2015 to 2023. Making the most of this healthy growth trajectory are the leading players within the geriatric medicines market: Bristol-Myers Squibb Company, Pfizer, Inc., Abbott Laboratories, Inc., Novartis AG, GlaxoSmithKline Plc., Eli Lilly and Company, Boehringer Ingelheim GmbH, Merck & Company Inc., AstraZeneca plc, and Sanofi S.A. Consistent efforts from these companies to cater to the growing demand for geriatric medicines is anticipated to push the market from a value of US$504.7 bn in 2014 to US$948 bn by 2023.

Browse Full Global Geriatric Medicines Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/geriatric-medicine-market.html

Nuclear Medicine Market Poised for Double-digit Growth!

Nuclear medicine refers to the application of radioactive isotopes for therapeutic and diagnostic purposes in medicine. The constituents of nuclear medicine include radioactive isotopes and radiological imaging devices such as magnetic resonance imaging (MRI), positron emission tomography (PET), computerized tomography (CT), and single proton emission tomography (SPECT). The basic principle of nuclear medicine is the use of radiological imaging devices to view the concentration of radioactive isotopes injected within the body thereby enabling a picture (2D) or real-time study (3D) of the patients anatomy. In some therapeutic applications, radioactive isotopes are selected in a way that they get excited when under the influence of radio waves from radiology equipment thereby treating a condition (mostly tumor) wherein the isotope is concentrated. Nuclear medicine has therefore seen a rise in their applicability over the past decades and is expected to continue with greater interests in treating life threatening diseases such as cancer.

Based on their application, nuclear medicines can be segregated majorly into: diagnostics and therapeutics. Diagnostic nuclear medicine can be further segmented into: cardiovascular, neurology, nephrology, hepatology, oncology, and pulmonology. The therapeutic applications of nuclear medicine majorly focus on cancer treatment and scar- tissue removal.

Available a Copy of Sample Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4672

Geographically, the nuclear medicine market is segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World. North America accounts for the largest share in terms of revenue due to several technological advancements and high cost associated with the nuclear medicines applications. Diagnostic nuclear medicine forms the largest application of nuclear medicine technology, radiopharmaceutical products and computer aided detection services in the region.

Therapeutic nuclear medicine follows diagnostic nuclear medicine in terms of applications. However therapeutic nuclear medicine being an expensive procedure has the potential to surpass diagnostic nuclear medicine in the future in terms of revenue. On the other hand European companies continue to remain a strong point in the global nuclear medicine market mainly due to the high quality of services offered, greater innovations and their increased reliability. Certain significant restrictions for nuclear medicine services such as shortage of radioactive isotopes, dearth of technical experts in hospitals and high cost of materials, continue to dampen the market growth especially in the cost sensitive economies of Asia Pacific region.

The demand for nuclear medicine services in the Asia Pacific region is expected to grow in the future due to increasing incidences of cancer, cardiovascular and neurological diseases, Australia, Japan, and China form the largest market in the Asia Pacific region as amajority of nuclear medicine diagnostic equipment manufacturing are from these countries. In addition Australia is among the world’s largest manufacturers of pharmaceutical radio-isotopes. South Asia and South East Asia on the other hand show great potential in terms of cardiovascular and neurological application. Therapeutic application of nuclear medicine for treating oncology cases are yet to be fully developed throughout the region, although countries such as Singapore exhibit a successful rate of nuclear medicine therapeutics.

Some of the key players contributing to the global nuclear medicine market include: G.E Healthcare, AIPES, COMECER S.P.A, Pinestar Technology, Inc., Ashby Gorman Baker Ltd, and Mediso Ltd.

Major Healthcare IT Vendors in the United States Pledge to Work on Interoperability

Interoperability has stood in the way of effective implementation of healthcare IT for a few years.

Now, in a move that could turn this situation around, leading healthcare IT developers from the United States (one of the largest healthcare IT markets in the world) have pledged to push interoperability in their respective products and systems.

According to an announcement by the Obama administration this week, major players such as Allscripts, Cerner Corp., Athenahealth, Meditech, and Epic Systems Corp. have said that they will work closely to improve interoperability in their electronic health record (EHR) systems. The announcement from HHS Secretary Sylvia Mathews Burwell came at the recent Healthcare Information and Management Systems Society convention, which was held in Las Vegas. 

What’s remarkable about this development is that the 17 vendors that have made the interoperability commitment currently provide healthcare IT and EHR systems and support to a whopping 90% of American hospitals. With this commitment, the companies said that their ultimate goal is to make it easier for patients in the United States to easily access and use their health-related records.

There are three major points on which the leading vendors have agreed:

• The companies would take adequate measures to ensure that patients are able to access their EHRs more easily and also, if the needed arises, transfer this data to another service provider or user. In short, enabling a user to transfer their data anywhere they want will be deemed important henceforth.
• Next, the group also committed to help their counterparts share healthcare information of individual users if directed or permitted by federal laws. Blocking healthcare records would likely be a thing of the past with this move. In the past, obstacles such as high fees or legal arrangements that restricted data transfer were detrimental to such an exchange.
• The third important development was that the group said it would stay committed to implementing applicable national interoperability standards. This would also likely involve the development of standardized applications so consumers could easily access data.

With the role of healthcare IT systems becoming more and more crucial, such a move will help improve healthcare data access and improve analytical acumen, said Burwell.

Aptamers Market to Expand at Whopping 73.1% CAGR 2013-2019 due to Increasing Advancements in Aptamer Technology

A new Transparency Market Research report states that the global aptamers market stood at US$0.93 bn in 2012 and is predicted to reach US$4.3 bn by 2019. It is predicted to expand at an extraordinary CAGR of 73.1% from 2013 to 2019. The title of the report is “Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

As stated in the report, the market for aptamers is fuelled by the rising interest of a number of research scientists in aptamer technology due to their numerous benefits over other antibodies. In addition, the growing participation and support from various private organizations in order to bring in advancements within the aptamers field will further fuel the global aptamers market. Furthermore, modifications within the aptamer chemistry resulting in increased acceptance emerged as key growth opportunities in the market. On the other hand, factors such as certain unfavorable characteristics of aptamers and the absence of knowledge amongst individuals may inhibit the growth of the market in the coming years.

In terms of type, the report segments the market into nucleic acid aptamers and peptide aptamers. Amongst these, the segment of nucleic acid aptamers is predicted to be the largest segment of the market for aptamers in the forecast horizon. The growth of this segment is owing to the rising utilization of nucleic acid aptamers within diagnostic applications and the increasing activities of research and development. Furthermore, this segment is poised to develop at the highest CAGR between 2013 and 2019. In addition, the growing usage of nucleic acid aptamers within the diagnostic field and analytical chemistry will also stimulate the market for nucleic acid aptamers. Clinical trials taking place for the development of novel therapeutic nucleic acid aptamers will also boost the growth of this segment in forthcoming years.

Request  a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1335

On the basis of application, the report segments the market into diagnostics, research and development applications, therapeutic development, and others. Amongst these, in 2012, the application segment of diagnostics led the market owing to the proliferation of numerous diagnostic kits by key players for in vitro diagnostic purposes. On the other hand, the application segment of therapeutics is predicted to expand at the highest CAGR from 2013 to 2019 owing to the rising activities of research and development in the aptamers market in order to develop novel therapeutic agents.

In terms of geography, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, in 2012, North America constituted the largest share of 45% in the market. This is owing to the presence of a huge number of chief players and the rising activities of research and development within this region. Europe trailed North America and held the second largest share in the market the same year. On the other hand, Asia Pacific is predicted to be the most rapidly growing aptamers market in the forecast horizon.

As mentioned in the report, the prominent players operating in the global aptamers market are Aptagen, Inc., Aptamer group, Aptamer Sciences, Inc., Somalogic, Inc., and NOXXAN Pharma AG.

IV Therapy and Vein Access Devices Market Propelled by Rising Incidence of Diabetes

A featured report, titled “IV Therapy and Vein Access Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” from Transparency Market Research (TMR) presents a strategic outlook on the market. The report analyzes trends including the advancement in technologies such as nanotechnology and minimally invasive procedures, projected to offer growth opportunities to companies operating in this market.

The most prominent companies operating in the global IV therapy and vein access devices market are Smiths Medical, Covidien, Insulet Corporation, Hospira, Teleflex, Medex, and Medtronic. Each player’s profile is examined in detail in the global IV therapy and vein access devices market report. Furthermore, the strategies adopted by these companies are also presented. This will allow companies to understand the key tactics adopted by market leaders. Moreover, the report also provides valuable recommendations to SMBs and MNCs as to how to penetrate a new market and expand their reach.

The types of devices offered by key manufacturers in the global IV therapy and vein access devices market are peripheral venous access, enteral feeding, central venous access, syringe infusion, diabetes insulin infusion devices, and implantable pumps.

Request a Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1656

The key trends driving the global IV therapy and vein access devices market are the growing number of surgical procedures and the rising number of trauma cases. Moreover, the rapidly growing incidence of several diseases such as cardiovascular disorders and diabetes will also boost the global IV therapy and vein access devices market. According to the WHO, around 347 mn people are suffering from diabetes. The rising incidence of diabetes is projected to boost the demand for insulin infusion pumps.

On the basis of region, the global IV therapy and vein access devices market is segmented into Europe, Asia Pacific, North America, and Rest of the World (RoW). At present, North America and Europe are leading the global IV therapy and vein access devices market. These regional markets are driven by trends such as the rising geriatric population and the presence of a well-established healthcare infrastructure.

Although Europe and North America are leading the global IV therapy and vein access devices market, it is Asia Pacific that is projected to witness the fastest growth during the forecast period from 2013 to 2019. The APAC IV therapy and vein access devices market is propelled by the rising prevalence of diabetes, kidney failure, and several other diseases, which is driving demand for these devices. The research report on the global IV therapy and vein access devices market offers a detailed analysis of the trends impacting each regional market. Furthermore, valuable statistics about these regional markets are also covered in the report.